Pepmixes to generate multiviral CTLs with broad specificity
AssigneeBaylor College of Medicine
InventorsAnn Marie Leen, Juan Fernando Vera Valdes, Cliona M. Rooney, Ulrike Gerdemann
Life of this patent
Estimating the term…
Abstract
The present invention concerns methods of generating CTLs that are able to target at least one antigen from two or more viruses. The method includes exposing mixtures of peptides for different antigens to the same plurality of PBMCs and, at least in certain aspects, expanding the cells in the presence of IL4 and IL7.
Claims14
A method of generating a polyclonal population of virus-specific T-lymphocytes (VSTs) that target at least one antigen from each of Epstein-Barr virus (EBV), cytomegalovirus (CMV), Adenovirus (Adv), BK virus (BKV), and human herpes virus 6 (HHV-6), comprising the steps of:
- directly contacting a plurality of peripheral blood mononuclear cells (PBMCs) with libraries of peptides, said libraries of peptides each comprising peptides that overlap in sequence to span part or all of a viral antigen;
- wherein the viral antigens comprise:
- a) EBV antigens EBNA1, LMP2, and BZLF1,
- b) CMV antigens IE1 and pp65,
- c) Adv antigens Hexon and penton,
- d) BK virus antigens LT and VP1, and
- e) HHV-6 antigens U14, U11, and U90;
- and
- expanding the plurality of cells in the presence of one or more cytokines,
- wherein the method is performed in the absence of isolated peptide-pulsed dendritic cells.
A method of generating a polyclonal population of virus-specific T-lymphocytes (VSTs) that target at least one antigen from each of Epstein-Barr virus (EBV), cytomegalovirus (CMV), Adenovirus (Adv), BK virus (BKV), and human herpes virus 6 (HHV-6), comprising the steps of:
- directly contacting a plurality of peripheral blood mononuclear cells (PBMCs) with libraries of peptides, said libraries of peptides each comprising peptides that overlap in sequence to span part or all of a viral antigen;
- wherein said libraries include peptides that span both immunodominant and subdominant antigens, wherein the viral antigens comprise:
- a) EBV antigens EBNA1, LMP2, and BZLF1,
- b) CMV antigens IE1 and pp65,
- c) Adv antigens Hexon and penton,
- d) BK virus antigens LT and VP1, and
- e) HHV-6 antigens U14, U11, and U90;
- and
- expanding the plurality of cells in the presence of one or more cytokines,
- wherein the method is performed in the absence of isolated peptide-pulsed dendritic cells, and wherein the population comprises VSTs specific for at least one immunodominant antigen and at least one subdominant antigen.
Dependencies are inferred from the claim text.